Search Results - Jean‐Jacques Grob
- Showing 1 - 20 results of 107
- Go to Next Page
-
1
Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: A randomized study by Sophie Girardi, C. Gaudy, Joanny Gouvernet, Jacques Teston, M.‐A. Richard, Jean‐Jacques Grob
Published 2005Artigo -
2
-
3
-
4
On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases by C. Gaudy‐Marqueste, Romain Carron, Christine Delsanti, Anderson Loundou, S. Monestier, E. Archier, M.‐A. Richard, Jean Régis, Jean‐Jacques Grob
Published 2014Artigo -
5
Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibod... by B Delaloye, A. Bischof-Delaloye, F. Buchegger, V von Fliedner, Jean‐Jacques Grob, J.-C. Volant, J Pettavel, J.-P. Mach
Published 1986Artigo -
6
-
7
-
8
-
9
-
10
-
11
-
12
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c mela... by Josep Malvehy, Igor Samoylenko, Dirk Schadendorf, Ralf Gutzmer, Jean‐Jacques Grob, Joseph J. Sacco, Kevin Gorski, Abraham Anderson, Cheryl A. Pickett, Kate Liu, Helen Gogas
Published 2021Artigo -
13
Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection by C. Gaudy‐Marqueste, Yanal Wazaefi, Y. Bruneu, Raoul Triller, L. Thomas, Giovanni Pellacani, Josep Malvehy, Marie‐Françoise Avril, S. Monestier, M.‐A. Richard, Bernard Fertil, Jean‐Jacques Grob
Published 2017Artigo -
14
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion by Reinhard Dummer, Paolo A. Ascierto, Nicole Basset‐Séguin, Brigitte Dréno, Claus Garbe, Ralf Gutzmer, Axel Hauschild, Regina Krattinger, John T. Lear, Josep Malvehy, Dirk Schadendorf, Jean‐Jacques Grob
Published 2020Revisão -
15
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study by Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer, Jean‐Jacques Grob, Emel Bülbül Başkan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon L. Spector, Karin Rosén
Published 2014Artigo -
16
An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma by Reinhard Dummer, Axel Hauschild, Juergen C. Becker, Jean‐Jacques Grob, Dirk Schadendorf, Veronica Tebbs, Jeannine Skalsky, Katharina C. Kaehler, Stephanie Moosbauer, Ruth Clark, Tze‐Chiang Meng, Mirjana Urosevic
Published 2008Artigo -
17
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial by Michele Maio, Jean‐Jacques Grob, Steinar Aamdal, Igor Bondarenko, Caroline Robert, L. Thomas, Claus Garbe, Vanna Chiarion‐Sileni, Alessandro Testori, Tai‐Tsang Chen, Marina Tschaika, Jedd D. Wolchok
Published 2015Artigo -
18
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study by Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer, Jean‐Jacques Grob, Emel Bülbül Başkan, Mary S. Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon L. Spector, Karin Rosén
Published 2014Errata/Corrigenda -
19
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline by Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Alan Spatz, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Published 2009Artigo -
20
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. by Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer
Cancer research
Melanoma
Immunotherapy
Pathology
Biology
Surgery
Metastatic melanoma
Dermatology
Ipilimumab
Randomized controlled trial
Adverse effect
Nivolumab
Paleontology
Stage (stratigraphy)
Clinical trial
Confidence interval
Alternative medicine
Clinical endpoint
Placebo
Gastroenterology
Vemurafenib
Pembrolizumab
Adjuvant
Chemotherapy
Hazard ratio
Dabrafenib